2021 annual financial data
CytoMed Therapeutics 2021 Financial results
Direct answer
Revenue was 84,178 SGD.
Operating income was -1,156,262 SGD and net income was -2,073,680 SGD.
Operating cash flow was -1,716,990 SGD.
Get free CytoMed Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 84,178 SGD
- Operating income
- -1,156,262 SGD
- Net income
- -2,073,680 SGD
- Operating cash flow
- -1,716,990 SGD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all CytoMed Therapeutics financial years